Decoy Therapeutics Inc.
DCOYNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $654.66K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.71$16.92
- Volume (live)
- -
- Avg. volume (3M)
- 4.57M
Decoy Therapeutics (DCOY) Stock Price & Financial Analysis
Decoy Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.16 - $1.26 |
|---|---|
| 52-Week High | $16.92 |
| 52-Week Low | $0.71 |
| Open | $1.26 |
| Volume (last close) | 35.78K |
| Average Volume (3M) | 4.57M |
| Revenue (TTM) | 227.63K |
|---|---|
| Net Income (TTM) | -14.45M |
| Free Cash Flow (TTM) | -8.37M |
| EPS (TTM) | −$28.51 |
| Profit Margin | -6347.85% |
| Operating Margin | -6421.34% |
| Return on Equity (ROE) | -334.41% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 654.66K |
|---|---|
| Shares Outstanding | 532.24K |
| Price to Sales (P/S) | 2.88 |
| Price to Book (P/B) | 0.15 |
| EV/EBITDA | 0.53 |
| 50-Day MA | $2.79 |
|---|---|
| 200-Day MA | $6.00 |
| 1-Year Change | −70.07% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Decoy Therapeutics at a Glance
As of the Oct 16, 2026 close, Decoy Therapeutics (DCOY) has a market capitalization of $654.66K. The stock trades at 2.9× sales. Over the trailing twelve months it lost $14.45M on revenue of $227.63K and burned $8.37M of free cash flow.
As of its latest reported balance sheet, it holds $8.29M in cash and securities against $0.00 of debt, a net cash position of $8.29M.
Decoy Therapeutics does not currently pay a dividend.
The share price is down 70.1% over the past year. At $1.17 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.71 to $16.92, below its 200-day moving average of $6.00.
Frequently Asked Questions About Decoy Therapeutics
What is the current stock price for DCOY?
As of the Oct 16, 2026 close, DCOY stock trades at $1.17. The 52-week range is $0.71–$16.92, with a day range of $1.16–$1.26.
What is the P/E ratio for DCOY?
The P/E ratio (Price-to-Earnings) for DCOY is shown in the Key Statistics section. This valuation metric helps compare Decoy Therapeutics Inc. to industry peers.
Does DCOY pay dividends?
Decoy Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for DCOY?
Analyst ratings and recommendations for DCOY are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of DCOY?
As of the Oct 16, 2026 close, Decoy Therapeutics's market capitalization is $622,723.14, classifying it as a micro-cap company. Decoy Therapeutics operates in the Healthcare sector within the Biotechnology industry.